Stewart Needleman

CDMOs to benefit from rising BTDs, orphan drugs and fast track status

The arrival of patient-centric CDMO's predicted by CPhI Annual Report  Frankfurt, November 13, 2019: CPhI Worldwide – the world's largest pharma…

5 years ago